Ads
related to: keytruda lung cancer treatment- Treatment Options
Learn About a Treatment Option
for Adjuvant NSCLC Here.
- Learn About NSCLC
Read More About NSCLC
and a Possible Treatment Option.
- Clinical Trial Results
See Clinical Trial Results
for an Early-Stage Treatment.
- Manage Side Effects
View Tips to Help Manage Side
Effects From Your Treatment.
- Resources and FAQ
Find Additional Patient Support
and Resources for NSCLC.
- Financial Assistance
Certain Patients Can Receive
Coverage & Assistance Information.
- Treatment Options
Search results
Merck (MRK) Gets CHMP Nod for Keytruda in Adjuvant Lung Cancer
Zacks via Yahoo Finance· 7 months agoMerck's (MRK) Keytruda gets a positive CHMP opinion, recommending the approval of the drug for the...
Merck (MRK) Keytruda Adjuvant Lung Cancer sBLA Accepted by FDA
Zacks via Yahoo Finance· 2 years agoThe FDA is expected to give its decision on Merck's (MRK) Keytruda sBLA for adjuvant stage IB-IIIA...
After Shelving Two Keytruda Trials, Merck Touts Encouraging Data From Keytruda Regime Study In Lung...
Benzinga via Yahoo Finance· 1 year agoMerck & Co Inc's (NYSE: MRK) Phase 3 KEYNOTE-671 trial investigating Keytruda met one of its dual...
Advanced Lung Cancer and Immunotherapy
Verywell Health via Yahoo News· 7 months agoImmunotherapy is a newer class of treatment for lung and other cancers. It primes the body’s natural immune system to fight back against cancer....
Five-Year Data For Merck's Keytruda Plus Chemo Shows Sustained Survival Benefit In Lung Cancer...
Benzinga via Yahoo Finance· 2 years agoMerck & Co Inc (NYSE: MRK) Keytruda plus chemotherapy demonstrated a survival benefit and durable...
The Surprising Way Mirati Therapeutics Is Angling To Rival Amgen — And Could Succeed
Investor's Business Daily· 2 years agoShares of MRTX stock rocketed Tuesday after Mirati Therapeutics unveiled early — but promising —...
Merck's lung cancer drug combo fails trial in setback for new therapy class
Reuters via AOL· 4 months agoMerck's experimental anti-TIGIT drug vibostolimab in combination with its approved therapy Keytruda...
Will Keytruda & Gardasil Aid Merck (MRK) Sales in Q4 Earnings?
Zacks via Yahoo Finance· 1 year agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor, Keytruda,...
Gilead's (GILD) Trodelvy Combo Shows Promise in NSCLC Study
Zacks via Yahoo Finance· 7 months agoGilead Sciences, Inc. GILD announced encouraging data from the mid-stage study evaluating its breast...
Merck, Eisai's combination therapy fails in lung cancer studies
Reuters via Yahoo News· 7 months agoThe pairing of Merck's blockbuster immunotherapy Keytruda and Eisai's Lenvima has previously failed...
Ads
related to: keytruda lung cancer treatment
